Doxy & Biaxin combo for lyme persisters

Anyone here try Doxy with Biaxin for lyme persisters? I've been on various ABX for 5 years now and am clearing up some remaining symptoms.

I thought doxy was generally used early on in treatment rather than at the end so I'm a little confused?
Doxycycline is used for later stage lyme as well.
Moderator, Lyme Forum
Symp started April/2013; Buhner's Lyme May 15-July24/14; Igenex pos. July 3/14
Doxy: July 4-Aug.24/14;Zithro July26-Aug24/14; Amox + Proben. Aug. 29/14;
added biaxin Sept. 26/14
Disc. amox,added Ceftin Nov. 20th.;
Disc. biaxin added Buhner bart herbs Dec/14;Jan/15 pulsing Tinda (w/ Ceftin);
Abx/herb break Apr-July/15; July-mino; Aug. added Rif;
Nov./15 mino - to biaxi
Here's a recent study on abx combos for persisters. Do a google search for the full 13 page white paper.


"Evaluation of Disulfiram Drug Combinations and
Identification of Other More Effective Combinations
against Stationary Phase Borrelia burgdorferi

Hector S. Alvarez-Manzo , Yumin Zhang, Wanliang Shi and Ying Zhang *
Department of Molecular microbiology and Immunology, Bloomberg School of Public Health,
Johns Hopkins University, Baltimore, MD 21205, USA; halvare3@jhu.edu (H.S.A.-M.);
yzhan424@jhmi.edu (Y.Z.); wshi3@jhu.edu (W.S.)
* Correspondence: medlife207@yahoo.com or yzhang@jhsph.edu
Received: 7 August 2020; Accepted: 25 August 2020; Published: 26 August 2020

Abstract: Lyme disease, caused by Borrelia burgdorferi, is the most common vector-borne disease in USA, and 10–20% of patients will develop persistent symptoms despite treatment (“post-treatment Lyme disease syndrome”). B. burgdorferi persisters, which are not killed by the current antibiotics for Lyme disease, are considered one possible cause. Disulfiram has shown to be active against B. burgdorferi, but its activity against persistent forms is not well characterized. We assessed disulfiram as single drug and in combinations against stationary-phase B. burgdorferi culture enriched with persisters. Disulfiram was not very effective in the drug exposure experiment (survival rate (SR) 46.3%) or in combinations. Clarithromycin (SR 41.1%) and nitroxoline (SR 37.5%) were equally effective when compared to the current Lyme antibiotic cefuroxime (SR 36.8%) and more active than disulfiram. Cefuroxime + clarithromycin (SR 25.9%) and cefuroxime + nitroxoline (SR 27.5%) were significantly more active than cefuroxime + disulfiram (SR 41.7%). When replacing disulfiram with clarithromycin or nitroxoline in three-drug combinations, bacterial viability decreased significantly and subculture studies showed that combinations with these two drugs (cefuroxime + clarithromycin/nitroxoline + furazolidone/nitazoxanide) inhibited the regrowth, while disulfiram combinations did not (cefuroxime + disulfiram + furazolidone/nitazoxanide). Thus, clarithromycin and nitroxoline should be further assessed to determine their role as potential treatment alternatives in the future."

Unfortunately nitroxoline is not available in US, nor is there a close equivalent at this time.

Post Edited (tickbite666) : 2/18/2021 3:06:17 PM (GMT-7)